| Mr Wendell Eugene Lewis Iii, APRN | |
|
209 W Main St, Battle Creek, NE 68715-4454 | |
| (402) 675-9065 | |
| (402) 675-9505 |
| Full Name | Mr Wendell Eugene Lewis Iii |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 209 W Main St, Battle Creek, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881988970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 111249 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Faith Regional Health Services Hospice | Norfolk, NE | Hospice |
| Faith Regional Health Services | Norfolk, NE | Hospital |
| Community Pride Care Center | Battle creek, NE | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faith Regional Physician Services Llc | 5193786168 | 162 |
News Archive
Cutting aid to Rwanda because of its alleged role in the ongoing conflict in the Democratic Republic of Congo (DRC), which is outlined in a November 2012 U.N. Security Council-commissioned report, "is the wrong approach," Tony Blair, founder of the Africa Governance Initiative, and Howard Buffett, president of the Howard G. Buffett Foundation, write in a Foreign Policy opinion piece, noting that the report, containing "allegations the government strongly denies, ... has led a number of Western governments and multilaterals to suspend aid to Rwanda, totaling $245 million."
UH professor of pharmacology Tahir Hussain has received $1.6M from the National Institutes of Health to examine a kidney cell that could prevent damage from inflammation caused by obesity.
Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.
After a significant increase in April, the Swedish public's confidence in government officials is now back at the same level as it was in March.
As if severely overweight people didn't already have enough health concerns, experts are raising another red flag - the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.
› Verified 9 days ago
| Entity Name | Faith Regional Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265489157 PECOS PAC ID: 5193786168 Enrollment ID: O20041022000558 |
News Archive
Cutting aid to Rwanda because of its alleged role in the ongoing conflict in the Democratic Republic of Congo (DRC), which is outlined in a November 2012 U.N. Security Council-commissioned report, "is the wrong approach," Tony Blair, founder of the Africa Governance Initiative, and Howard Buffett, president of the Howard G. Buffett Foundation, write in a Foreign Policy opinion piece, noting that the report, containing "allegations the government strongly denies, ... has led a number of Western governments and multilaterals to suspend aid to Rwanda, totaling $245 million."
UH professor of pharmacology Tahir Hussain has received $1.6M from the National Institutes of Health to examine a kidney cell that could prevent damage from inflammation caused by obesity.
Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.
After a significant increase in April, the Swedish public's confidence in government officials is now back at the same level as it was in March.
As if severely overweight people didn't already have enough health concerns, experts are raising another red flag - the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Wendell Eugene Lewis Iii, APRN 209 W Main St, P.o. Box 160, Battle Creek, NE 68715-4454 Ph: (402) 675-9065 | Mr Wendell Eugene Lewis Iii, APRN 209 W Main St, Battle Creek, NE 68715-4454 Ph: (402) 675-9065 |
News Archive
Cutting aid to Rwanda because of its alleged role in the ongoing conflict in the Democratic Republic of Congo (DRC), which is outlined in a November 2012 U.N. Security Council-commissioned report, "is the wrong approach," Tony Blair, founder of the Africa Governance Initiative, and Howard Buffett, president of the Howard G. Buffett Foundation, write in a Foreign Policy opinion piece, noting that the report, containing "allegations the government strongly denies, ... has led a number of Western governments and multilaterals to suspend aid to Rwanda, totaling $245 million."
UH professor of pharmacology Tahir Hussain has received $1.6M from the National Institutes of Health to examine a kidney cell that could prevent damage from inflammation caused by obesity.
Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.
After a significant increase in April, the Swedish public's confidence in government officials is now back at the same level as it was in March.
As if severely overweight people didn't already have enough health concerns, experts are raising another red flag - the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.
› Verified 9 days ago